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 Phosphate is essential in several crucial 
biological processes, including cellular 
energy metabolism, nucleic acid synthe-
sis, cell signaling, energy metabolism, and 
bone mineralization. Alterations in serum 
phosphate are associated with various 
pathological eff ects. Hypophosphatemia 
is common in rickets, osteomalacia, and 
other diseases, and hyperphosphatemia 
in chronic kidney disease has been dem-
onstrated to cause increased risk of car-
diovascular morbidity and mortality. 
More over, elevated phosphate concentra-
tions in subjects with normal kidney 
function are also associated with 
increased cardiovascular risk and mortal-
ity. 1 Th erefore it is important to identify 
the mechanisms involved in phosphate 
homeostasis. Phosphate balance is coor-
dinated by a complex process involving 
various organs and tissues, including the 
intestine, kidney, parathyroid gland, and 
bone as well as the vitamin D system and 
phosphatonins. Among the organs, the 
kidney has a key function in phosphate 
metabolism due to its ability to excrete 
phosphate and to control bone and min-
eral metabolism through the activation of 
vitamin D. 
 Phosphate transport in the small intestine 
and renal tubules is mediated mainly by 
three type II sodium – phosphate cotrans-
porters: NaPi-2a (SLC34A1), NaPi-2b 
(SLC34A2), and NaPi-2c (SLC34A3). NaPi-
2a is commonly expressed in the apical 
brush border membrane of the renal proxi-
mal tubule (highest in S1 segments and 
gradually decreasing toward S3 segments), 
and it is responsible for most of the renal 
phosphate reabsorption. In contrast, 
NaPi-2c protein is detected in S1 and S2 
and is absent in S3 segments. Th is trans-
porter has been associated with growth, 
as its abundance is at its maximum aft er 
weaning and decreases in the adult. Both 
NaPi-2a and NaPi-2c transport divalent 
phosphate ions (HPO 4   2 −   ), but with diff er-
ent stoichiometries. Th ree Na   +   ions are 
transported together with one HPO 4   2 −  
ion by NaPi-2a, whereas NaPi-2c exhibits 
a 2Na   +   / HPO 4   2 −   stoichiometry. Th erefore, 
transport by NaPi-2a is electrogenic, 
whereas transport by NaPi-2c is elec-
troneutral ( Figure 1 ). 2 NaPi-2b is mostly 
loca lized in the small intestine and is sen-
sitive to vitamin D. NaPi-2b has a low 
affi  nity for phosphate, and patients with 
NaPi-2b-inactivating mutations do not 
exhibit reduced serum phosphate levels, 
which would be expected in the case of 
the lack of a key transporter. However, 
studies in a conditional NaPi-2b-null 
mouse model demonstrated that deletion 
of NaPi-2b resulted in an increase in the 
expression of NaPi-2a in the renal proximal 
tubule and serum phosphate concentra-
tions remained normal, most likely owing 
to compensatory renal reabsorption. 3 
Intestinal phosphate absorption may have 
an eff ect on renal phosphate handling, 
perhaps, as recently suggested, by secre-
tion of peptides derived from the intes-
tine. 4 Recently, it was reported that mice 
knockout for both NaPi-2a and NaPi-2c, 
while showing severe hypophosphatemia, 
still had some renal phosphate reabsorp-
tion. 5 Th ese results imply the involvement 
of other secondary active phosphate trans-
porters along the nephron. Recent fi nd-
ings suggest that Pit-2, so far regarded as 
a ubiquitously expressed housekeeping 
phosphate transporter, is a new mediator 
of phosphate reabsorption in the proximal 
tubule, but with a diff erent adaptive time 
course than NaPi-2a and NaPi-2c. 6 
 The reabsorption of phosphate by 
the intestine and kidney is controlled by 
various hormones and peptides, including 
vitamin D, parathyroid hormone, and the 
phosphatonins, such as fi broblast growth 
factor 23, which act to increase intestinal 
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phosphate absorption or reduce the amount 
of phosphate retained by the kidney. 7 
 Serum- and glucocorticoid-inducible 
kinase 1 (SGK1) was originally cloned as 
an immediate-early gene whose tran-
scription was stimulated by serum and 
glucocorticoids in rat mammary tumor 
cells. Th e human isoform has been shown 
to be a cell-volume-regulated gene upreg-
ulated by cell shrinkage. Two closely 
related isoforms, SGK2 and SGK3, have 
subsequently been identifi ed that share 
80 % amino acid sequence identity in 
their catalytic domain with SGK1. 8 SGKs 
are expressed in a wide variety of species, 
including sharks. In mammals, SGK1 and 
SGK3 are expressed in virtually all tissues 
tested. SGKs have been implicated in sev-
eral functions. All three kinases are 
potent regulators of ion channel activity, 
transport, and transcription. 9 More 
information has been obtained by the 
functional analysis of gene-targeted mice 
lacking SGK1 and SGK3. Interestingly, 
neither knockout of SGK1 or SGK3 nor 
knockout of both SGK1 and SGK3 leads 
to a severe phenotype, suggesting that 
neither SGK1 nor SGK3 is required for 
survival. Closer inspection of the physi-
ology of those mice, however, reveals 
several physiological defi cits pointing 
toward a wide functional role of these 
kinases. With respect to SGK3,  Sgk3 -null 
mice are viable and fertile and, in con-
trast to mice lacking SGK1, display nor-
mal sodium handling and glucose 
tolerance. However, although normal at 
birth, by postpartum day 4 they begin to 
display an unexpected defect in hair fol-
licle morphogenesis. 
 Bhandaru  et al. 10 (this issue) studied the 
role that SGK3 may have in the regulation 
of renal tubular transport of phosphate in 
gene-targeted mice lacking functional 
SGK3 ( sgk3KO ) as well as wild-type mice 
( sgk3WT ). Th e experiments revealed a 
signifi cant increase in the absolute and 
fractional excretion of phosphate in 
 sgk3KO mice as compared with  sgk3WT 
mice with no significant change in 
glomerular filtration rate and normal 
plasma Ca 2  +   , phosphate and glucose con-
centrations. Th e plasma parathyroid hor-
mone level was similar in both genotypes, 
but plasma 1,25(OH) 2 D 3 and fi broblast 
growth factor 23 concentrations were sig-
nifi cantly lower in  sgk3KO than in  sgk3WT 
mice. Moreover, bone density was slightly 
but signifi cantly lower in  sgk3KO than in 
 sgk3WT mice. The effect of SGK3 on 
NaPi-2a was further investigated in the 
 Xenopus oocyte system. SGK3 with NaPi-
2a indeed significantly enhanced 
phosphate-induced current in NaPi-2a-
expressing  Xenopus oocytes. 
 Experiments in brush border mem-
brane vesicle preparations from  sgk3KO 
and  sgk3WT mice were performed 
to determine the sodium-dependent 
transport of phosphate  ex vivo . Surpris-
ingly, the protein expression of the phos-
phate transporters NaPi-2a, NaPi-2c, and 
Pit-2 in brush border membrane fractions 
was not diff erent between the geno types. 
Th e transcription levels of these transport-
ers were similarly not signifi cantly diff er-
ent between  sgk3KO and  sgk3WT mice. 
 Th e mild phosphaturia of  sgk3KO mice 
indicates that SGK3 is indeed involved in 
the regulation of renal tubular phosphate 
transport. Such an eff ect occurs independ-
ently of the plasma concentration of both 
phosphate and parathyroid hormone. As 
the authors point out, 10 one possible expla-
nation may be related to 1,25(OH) 2 D 3 , 
which was significantly decreased in 
 sgk3KO mice. Possibly, SGK3 participates 
in the regulation of 1,25(OH) 2 D 3 forma-
tion, which has been previously shown to 
be stimulated by insulin-like growth factor 1. 
Since 1,25(OH) 2 D 3 stimulates renal tubular 
phosphate transport ,  decreased 
1,25(OH) 2 D 3 formation could contribute 
to the phosphaturia of  sgk3KO mice. 
 Although these results are quite inter-
esting, there are several points that need 
to be clarified by further studies. First 
of all, it is very important to investigate 
whether increased urinary phosphate 
excretion is paralleled by enhanced intes-
tinal phosphate absorption. Th e authors 
do not show data about the food intake 
and the expression of intestinal phosphate 
transporters such as NaPi-2b. Th is could 
be helpful in discriminating whether the 
increased food intake is the primary event 
leading to hyperphosphaturia even in the 
low-phosphate-diet model. Evidence has 
shown that dietary phosphate can modu-
late urinary phosphate excretion in a vita-
min D-independent manner. In addition, 
the phosphaturia of  sgk3KO mice was not 
paralleled by a decrease of either the phos-
phate transport across brush border mem-
brane vesicles or the mRNA and protein 
abundance of the phosphate transporters. 
Th is eff ect is seemingly in contrast to the 
powerful effect of SGK3 on NaPi-2a 
expression in  Xenopus oocytes. 
 It is entirely possible that the mecha-
nism of the loss of phosphate in  sgk3KO 
mice, so far unidentifi ed, is completely 
new in this fi eld. Future studies in this 
area should be very interesting. 
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 Figure 1  |  Expression of phosphate transporters along the segments of the proximal tubule 
and their subcellular localization. NaPi-2a is expressed progressively less abundantly along the 
entire proximal tubule. NaPi-2c is localized in the S1 and S2 proximal tubule segments. Pit-2 is 
expressed along the entire proximal tubule. 
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 In this issue of  Kidney International , Zhang 
 et al. 1 report a carefully performed study 
in which they addressed the important 
question of the role of mitochondria-
related oxidative stress in the development 
of hypertension. Th ey show that the mito-
chondrial respiratory chain complex I 
inhibitor rotenone signifi cantly attenuated 
deoxycorticosterone acetate (DOCA)-salt-
induced hypertension and urinary 8-iso-
prostane excretion, and reduced reactive 
oxygen species production in isolated kid-
ney mitochondria. Other mitochondrial 
inhibitors, including 5-hydroxydecanoate, 
a mitochondrial ATP-sensitive potassium 
channel inhibitor; benzylguanidine, an 
inhibitor of complexes I and III; and man-
ganese tetrakis (4-benzoic acid) porphy-
rin, an antioxidant, similarly attenuated 
DOCA-salt-induced hypertension. In 
contrast, mice deficient in gp91 phox or 
p47 phox , both subunits of NAD(P)H oxi-
dase, exhibited only a partial attenuation 
of hypertension at early stages following 
the DOCA-salt treatment. Th e authors 
conclude that the mitochondrial respira-
tory chain, not NAD(P)H oxidase, is a 
major source of oxidative stress in mice 
with DOCA-salt-induced hypertension. 
 Th e study provides further support for 
the increasing recognition that mitochon-
dria-related oxidative stress contributes to 
the development of hypertension. Hyper-
tension in several animal models has been 
shown to be attenuated by inhibition of 
mitochondrial generation of reactive oxy-
gen species or elevation of the antioxida-
tive capacity of mitochondria. For example, 
administration of mitoTEMPO 2 or 
MitoQ10 3 or overexpression of the mito-
chondrial superoxide dismutase SOD2 2 or 
the thioredoxin TXN2 4 has been reported 
to attenuate angiotensin II-induced hyper-
tension in mice or the development of 
hypertension in the  spontaneous hyper-
tensive rat. Conversely, tissue-specific 
hypermethylation of the  Sod2 gene was 
associated with pulmonary arterial 
 hypertension in the fawn-hooded rat com-
pared with a protected consomic strain. 5 
Gene hypermethylation is oft en associated 
with transcriptional inhibition. In addi-
tion, knock-down of uncoupling protein 2 
potentiated oxidative stress and hyperten-
sion induced by intracerebroventricular 
infusion of angiotensin II. 6 Uncoupling 
protein 2 can mitigate mitochondrial pro-
duction of reactive oxygen species. 
 Mitochondria represent one of several 
possible sources of cellular reactive oxy-
gen species. Th e relative importance of 
various sources of reactive oxygen species 
to the development of hypertension is 
oft en not clear. Th e study by Zhang  et al. 1 
suggests that NAD(P)H oxidase is of lim-
ited importance in the development of 
hypertension in the DOCA-salt model. As 
the authors acknowledge, it is not entirely 
clear why their current findings differ 
from those of previous studies that have 
reported important roles of NAD(P)H 
oxidase subunits in this model of hyper-
tension. Th e authors emphasize that the 
methods of blood pressure measurement 
were diff erent among the studies. Th eir 
current study used radiotelemetry. Mito-
chondria and NAD(P)H oxidase may not 
be mutually exclusive sources of reactive 
oxygen species aft er all. Reactive oxygen 
species generated from one source could 
stimulate the production from another 
source, as discussed by Zhang  et al. 1 
 A key question is the relationship 
between initiating causes of hypertension 
and mitochondria-related oxidative stress. 
In the DOCA-salt model, the treatment 
(DOCA and increased salt intake) may 
induce mitochondrial oxidative stress, 
which then contributes to the develop-
ment of hypertension. Alternatively, the 
treatment may initiate the development of 
hypertension, leading to secondary mito-
chondrial oxidative stress, which then 
exacerbates hypertension. In complex 
genetic models of hypertension such as 
the Dahl salt-sensitive (SS) rat, oxidative 
stress could be in part genetically deter-
mined and present prior to a high-salt 
challenge. Increased salt intake may 
worsen oxidative stress or interact with 
existing oxidative stress in other ways, 
leading to the rapid and progressive 
increase in arterial blood pressure 
observed in the SS rat. 
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 The molecular pathophysiology of hypertension is probably like a jigsaw 
puzzle of different but overlapping sets of factors and pathways that 
vary from one patient or one group of patients to another. Mitochondrial 
and metabolic abnormalities could be crucial pieces of this puzzle. 
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